within Pharmacolibrary.Drugs.ATC.R;

model R06AE03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.83,
    Cl             = 0.5,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.016,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.002,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Cyclizine is a first-generation antihistamine with antiemetic, anticholinergic, and mild sedative properties, commonly used for the prevention and treatment of nausea, vomiting, and vertigo associated with motion sickness, postoperative states, and certain other conditions. It remains in clinical use today, though newer antiemetics are often preferred in some settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult individuals after oral administration due to lack of detailed compartmental modeling in the literature.</p><h4>References</h4><ol><li><p>Vella-Brincat, JW, et al., &amp; Reid, K (2012). The pharmacokinetics and pharmacogenetics of the antiemetic cyclizine in palliative care patients. <i>Journal of pain and symptom management</i> 43(3) 540–548. DOI:<a href=&quot;https://doi.org/10.1016/j.jpainsymman.2011.04.022&quot;>10.1016/j.jpainsymman.2011.04.022</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22209223/&quot;>https://pubmed.ncbi.nlm.nih.gov/22209223</a></p></li><li><p>Paterson, S (1992). Pharmacokinetics of dipipanone after a single oral dose. <i>British journal of clinical pharmacology</i> 33(4) 449–450. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1992.tb04066.x&quot;>10.1111/j.1365-2125.1992.tb04066.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1349495/&quot;>https://pubmed.ncbi.nlm.nih.gov/1349495</a></p></li><li><p>Ruben, SM, et al., &amp; Melville, J (1989). Cyclizine abuse among a group of opiate dependents receiving methadone. <i>British journal of addiction</i> 84(8) 929–934. DOI:<a href=&quot;https://doi.org/10.1111/j.1360-0443.1989.tb00766.x&quot;>10.1111/j.1360-0443.1989.tb00766.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2775912/&quot;>https://pubmed.ncbi.nlm.nih.gov/2775912</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R06AE03;
